KAS
APTO

Kestra Advisory Services’s Aptose Biosciences, Inc. APTO Stock Holding History

Kestra Advisory Services’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-24
Closed -$15K – 2150
2021
Q4 		$15K Buy
+24
New +$22.6K ﹤0.01% 1998
2021
Q1 		– Sell
-24
Closed -$47K – 2093
2020
Q4 		$47K Buy
+24
New +$56.4K ﹤0.01% 1818

Other funds holding APTO

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Kestra Advisory Services's APTO Position: Q1 2022 in Review

Kestra Advisory Services sold out of Aptose Biosciences, Inc. (APTO) in Q1 2022, closing a stake of 24 shares — an estimated $15K sold.

Kestra Advisory Services first reported a position in APTO in Q4 2020 and held it in 2 quarters. The position peaked at $47K in Q4 2020. 52 funds tracked by Wall St. Rank hold APTO as of Q1 2022.

  • Kestra Advisory Services reported no remaining Aptose Biosciences, Inc. position as of Q1 2022 after selling out during the quarter.
  • Kestra Advisory Services sold 24 Aptose Biosciences, Inc. shares in Q1 2022, an estimated $15K.
  • Kestra Advisory Services first reported a position in Aptose Biosciences, Inc. in Q4 2020 and held it in 2 quarters.
  • Kestra Advisory Services's Aptose Biosciences, Inc. position peaked at $47K in Q4 2020.
  • 52 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q1 2022.

Based on Kestra Advisory Services's 13F filing for Q1 2022, filed 26 Apr 2022.